| 2024-05-18 |
[Articles] Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis |
Muhammad Shariq Usman, Deepak L Bhatt, Ishaque Hameed, Stefan D Anker, Alice Y Y Cheng, Adrian F Hernandez, William Schuyler Jones, Muhammad Shahzeb Khan, Mark C Petrie, Jacob A Udell, Tim Friede, Javed Butler |
|
| 2024-05-18 |
[Comment] SGLT2 inhibitors in clinical practice |
Lars Rydén, Anna Norhammar |
|
| 2024-05-11 |
[Editorial] Sleep: a neglected public health issue |
The Lancet Diabetes & Endocrinology |
|
| 2024-05-07 |
[Review] Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review |
Moath S Alsaqaaby, Sarah Cooney, Carel W le Roux, Dimitri J Pournaras |
|
| 2024-05-07 |
[Correspondence] Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care |
Ezio Bonifacio, Christiane Winkler, Peter Achenbach, Anette-Gabriele Ziegler |
|
| 2024-05-07 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 233–46 |
|
|
| 2024-05-07 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 301–02 |
|
|
| 2024-05-04 |
[Articles] Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies |
Yanping Li, Tianyi Huang, Susan Redline, Walter C Willett, JoAnn E Manson, Eva S Schernhammer, Frank B Hu |
|
| 2024-05-04 |
[Comment] Melatonin: is it really a cardiovascular wonder pill for shift workers? |
Pei Xue, Diana A Nôga, Christian Benedict |
|
| 2024-04-30 |
[Articles] Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial |
Christian L Roth, Cecilia Scimia, Ashley H Shoemaker, Michael Gottschalk, Jennifer Miller, Guojun Yuan, Sonali Malhotra, M Jennifer Abuzzahab |
|
| 2024-04-30 |
[Articles] Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial |
Katrien Benhalima, Kaat Beunen, Nancy Van Wilder, Dominique Ballaux, Gerd Vanhaverbeke, Youri Taes, Xavier-Philippe Aers, Frank Nobels, Joke Marlier, Dahae Lee, Joke Cuypers, Vanessa Preumont, Sarah E Siegelaar, Rebecca C Painter, Annouschka Laenen, Piete |
|
| 2024-04-30 |
[Comment] Demarcating the benefits of hybrid closed loop therapy in pregnant women with type 1 diabetes |
Helen R Murphy, Eleanor M Scott |
|
| 2024-04-30 |
[Comment] Setmelanotide: new promise for the treatment of hypothalamic obesity? |
Manuel Tena-Sempere |
|
| 2024-04-25 |
[Comment] Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE |
Dennis M Black, Austin R Thompson, Richard Eastell, Mary L Bouxsein |
|
| 2024-04-20 |
[Editorial] Earth Day: time for transformational change |
The Lancet Diabetes & Endocrinology |
|
| 2024-04-18 |
[Correspondence] Improving support for university students with type 1 diabetes |
Gijsbert Stoet, Emily Foster, Catherine Kerr, Lingqing Jiang, Megan-Ann Thornhill, Katarzyna Cyranka, Bartłomiej Matejko, Dominika Sarna-Palacz, Magdalena Płonka-Stępień, Tomasz Klupa |
|
| 2024-04-09 |
[Review] Endocrine health in survivors of adult-onset cancer |
Cornelia S Link-Rachner, Andy Göbel, Nikolai P Jaschke, Tilman D Rachner |
|
| 2024-04-06 |
[Articles] Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study |
Victoria Miller, David A Jenkins, Mahshid Dehghan, Kristie Srichaikul, Sumathy Rangarajan, Andrew Mente, Viswanathan Mohan, Sumathi Swaminathan, Rosnah Ismail, Maria Luz Diaz, Rekha M Ravindran, Katarzyna Zatonska, Ahmad Bahonar, Yuksel Altuntas, Rasha Kh |
|
| 2024-04-06 |
[Comment] Glycaemic index as part of the diabetes prevention strategy |
Gary Frost |
|
| 2024-04-06 |
[In Focus] Direct-to-consumer services: improving access to care for people with diabetes and obesity |
Talha Burki |
|
| 2024-03-30 |
[Articles] Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort study |
Yuxia Wei, Shengxin Liu, Tomas Andersson, Maria Feychting, Ralf Kuja-Halkola, Sofia Carlsson |
|
| 2024-03-30 |
[Comment] Type 1 diabetes: heterogeneity in heritability |
Richard David Leslie |
|
| 2024-03-28 |
[Articles] Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis |
Cholesterol Treatment Trialists’ (CTT) Collaboration |
|
| 2024-03-28 |
[Comment] How clinically relevant is statin-induced diabetes? |
Hertzel C Gerstein, Marie Pigeyre |
|
